- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Gastric
Clinical Trial Search
Trial Protocol ID
USOR 23165_TT420C2308_FIRST-308 *STAR*
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician's Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
Trial Protocol ID
USOR 23066_TAS-120-205 *STAR*
Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements